|
||
|
||
| [Home Page] [Previous Menu] [Search] |
B-GT/9: Regulatory and clinical data
(Authors: M. Sneyers and M. Goossens - Last revised:
February 28, 2006
)
Title |
A phase I feasibility trial of a live, genetically modified Salmonella typhimurium bacillus (VNP20009) for the treatment of cancer by intra-tumoral injection |
Company or sponsor |
Vion Pharmaceuticals, Inc. |
Pharmaceutical study code |
CLI-007 |
Phase |
I |
Unicenter/multicenter study |
unicenter |
| Clinical data | see table 2 |
Installation |
Universitair Ziekenhuis Gasthuisberg, Leuven |
Authorisation procedure |
contained use, new operation (see relevant regulation) |
Application number |
SBB 219 99/0430 |
User(s) |
Prof. Dr P. Lambin, Dr H. Dumez and Prof. Dr J. Anné |
Receipt date |
25/06/1999 |
Biosafety Council meeting date |
26/10/1999 |
Authorisation date |
17/12/1999
|
Status |
trial was never started in Belgium |
|